Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Real-world impact of adding a glucagon-like peptide-1 receptor agonist compared with basal insulin on metabolic targets in adults living with type 2 diabetes and chronic kidney disease already treated with a sodium-glucose co-transporter-2 inhibitor: the impact GLP-1 CKD study
The short answer is that there is no known contraindication to taking Pepto-Bismol whilst on Wegovy, and no clinically significant interaction has been documented between these medications according to their respective UK product information
Although it is not uncommon to use an SGLT2 inhibitor alongside a diuretic for CHF, the combination could prompt dehydration
Complete a quick medical evaluation from anywhere in the United States and, if appropriate, incorporate compounded semaglutide or tirzepatide as part of a broader plan that also considers diet and exercise
Response from the owner: Thank you so much Aubrie
